Published in J Am Soc Nephrol on March 01, 2001
Mammalian collagen IV. Microsc Res Tech (2008) 2.56
Role of T cells and dendritic cells in glomerular immunopathology. Semin Immunopathol (2007) 1.08
Leukocyte-derived interleukin-1beta interacts with renal interleukin-1 receptor I to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis. Am J Pathol (2004) 1.06
Kidney Dendritic Cells Become Pathogenic during Crescentic Glomerulonephritis with Proteinuria. J Am Soc Nephrol (2010) 1.05
Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis. J Am Soc Nephrol (2009) 1.01
Poly(ADP-ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death and modulating inflammation. J Immunol (2009) 0.92
Overlapping roles of endothelial selectins and vascular cell adhesion molecule-1 in immune complex-induced leukocyte recruitment in the cremasteric microvasculature. Am J Pathol (2003) 0.91
Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN. J Am Soc Nephrol (2014) 0.82
The Players: Cells Involved in Glomerular Disease. Clin J Am Soc Nephrol (2016) 0.75
The association between interleukin-19 concentration and diabetic nephropathy. BMC Nephrol (2017) 0.75
Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J Clin Invest (1981) 2.41
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum (1999) 2.17
Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J Am Soc Nephrol (1999) 2.11
Tissue culture of isolated glomeruli in experimental crescentic glomerulonephritis. J Exp Med (1978) 2.02
The macrophagen in human rapidly progressive glomerulonephritis. Lancet (1976) 1.88
Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int (1997) 1.66
Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int (1999) 1.55
Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab Invest (1991) 1.49
Role of CFTR mutations in adult bronchiectasis. Thorax (2004) 1.46
Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med (2000) 1.44
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum (1998) 1.39
Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med (1997) 1.38
T lymphocyte participation in antibody-induced experimental glomerulonephritis. Kidney Int (1985) 1.36
Antibody independent crescentic glomerulonephritis in mu chain deficient mice. Kidney Int (1997) 1.35
Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis. Lancet (1988) 1.32
Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. J Clin Invest (1985) 1.31
The macrophage in the development of experimental crescentic glomerulonephritis. Studies using tissue culture and electron microscopy. Am J Pathol (1979) 1.31
The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: studies using glomerular culture and electronmicroscopy. Clin Exp Immunol (1979) 1.28
IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis. J Am Soc Nephrol (1999) 1.27
Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin Exp Immunol (1997) 1.25
Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood (1999) 1.25
Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol (1997) 1.23
Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int (1994) 1.23
P-selectin directs T lymphocyte-mediated injury in delayed-type hypersensitivity responses: studies in glomerulonephritis and cutaneous delayed-type hypersensitivity. Eur J Immunol (1996) 1.19
Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol Renal Physiol (2001) 1.19
A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int (1994) 1.16
TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy. J Autoimmun (2010) 1.16
Tissue culture of isolated human glomeruli. Pathology (1978) 1.15
Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis. Kidney Int (2000) 1.15
Procoagulant activity expression by macrophages from atheromatous vascular plaques. Atherosclerosis (1989) 1.15
Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest (1988) 1.14
Glomerulonephritis, Th1 and Th2: what's new? Clin Exp Immunol (2005) 1.10
Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol (1995) 1.08
Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry. Clin Exp Immunol (2005) 1.07
Cellular immune mechanisms in human glomerulonephritis: the role of mononuclear leucocytes. Springer Semin Immunopathol (1982) 1.07
Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Am J Pathol (1995) 1.06
The participation of macrophages and monocytes in experimental immune complex glomerulonephritis. Clin Immunol Immunopathol (1980) 1.06
Macrophage-induced glomerular injury. Cell transfer studies in passive autologous antiglomerular basement membrane antibody-initiated experimental glomerulonephritis. Lab Invest (1984) 1.06
Antiinflammatory effect of lipocortin 1 in experimental arthritis. Inflammation (1997) 1.05
Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. Kidney Int (1991) 1.04
Interleukin-8 production by macrophages from atheromatous plaques. Arterioscler Thromb Vasc Biol (1996) 1.04
Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA. Am J Pathol (1995) 1.02
Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. Kidney Int (1998) 1.01
IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur J Immunol (1999) 1.01
Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin Exp Immunol (1997) 1.00
Cell characteristics of cultured glomeruli from different animal species. Nephron (1978) 0.99
The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits. Am J Pathol (1986) 0.98
Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int (1997) 0.98
Hydroxyl radical mediation of immune renal injury by desferrioxamine. Kidney Int (1986) 0.97
Effect of cyclosporin A on antibody-induced experimental glomerulonephritis. Nephron (1985) 0.97
The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis. Clin Exp Immunol (1978) 0.96
Interleukin-10 inhibits macrophage-induced glomerular injury. J Am Soc Nephrol (2000) 0.96
Lymphokine (MIF) production by glomerular T-lymphocytes in experimental glomerulonephritis. Kidney Int (1986) 0.96
Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. J Exp Med (1998) 0.96
A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. Br J Exp Pathol (1986) 0.93
Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis (1995) 0.92
Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis. Clin Exp Immunol (2002) 0.92
Tissue culture of isolated glomeruli from patients with glomerulonephritis. Kidney Int (1980) 0.92
Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury. Diabetologia (2010) 0.92
Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives. Am J Hematol (1999) 0.91
Pulmonary manifestations of the clinical syndrome of acute glomerulonephritis and lung hemorrhage. Am J Kidney Dis (1986) 0.91
Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen-presenting cells. Br J Pharmacol (2012) 0.91
Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease. Diabetologia (2007) 0.91
IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studies in cell-mediated crescentic glomerulonephritis. J Immunol (2000) 0.90
Alveolar macrophage procoagulant activity is increased in acute hyperoxic lung injury. Am J Pathol (1988) 0.90
Crescentic glomerulonephritis--a manifestation of a nephritogenic Th1 response? Histol Histopathol (2000) 0.90
Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis. Kidney Int (1989) 0.89
Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis. Am J Pathol (1997) 0.89
Evidence for direct renal injury as a consequence of glomerular complement activation. J Immunol (1986) 0.89